Stephen Y. Nakada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stephen Y. Nakada has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Sutchin R. Patel
Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792-7375, USA
6 shared publications- Sutchin Rashmikant Patel
University of Wisconsin School of Medicine and Public Health
6 shared publications - Kristina L. Penniston
Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
5 shared publications Daniel M. Kaplon
University of Wisconsin Hospital and Clinics
4 shared publicationsKristina L. Penniston
University of Wisconsin School of Medicine and Public Health
4 shared publications- Sara L. Best
Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
4 shared publications
Latest Publications
- Open Access
- 23 March 2025
- Published by Wiley in BJUI Compass
- Vol. 6 (3) , e70007
Risk factors for readmission after ureteroscopy for stone disease: Modern single centre experience
Objectives: To identify factors that increase a patient's risk of readmission in the immediate postoperative period following ureteroscopy.Materials and Methods: An IRB‐approved surgical database of patients with renal and ureteral stones at a single institution was retrospectively analysed for patients who underwent ureteroscopies and had 30 days follow‐up from September 2016 to June 2019. We reviewed the most recent 600 cases (300 consecutive women and 300 consecutive men). Patient characteristics including gender, body mass index (BMI) and comorbidities (hypertension, gout, diabetes mellitus (DM), recurrent urinary tract infections (UTIs), chronic kidney disease (CKD), bowel disease), history of preoperative ED visit and surgical factors (preoperative stent, stone size) were used to conduct univariate and multivariable logistic regression analysis. Outcome measures included readmission within 30 days postoperatively. Exclusion criteria included age <18 and 0.05). Patients were more likely to have a postoperative admission if they were older (age 68 ± 15 vs 56 ± 15, p < 0.002; OR 1.06; 95% CI 1.01–1.10, p = 0.01) or had a history of recurrent UTIs (OR 7.40, 95%CI 1.78–30.67, p = 0.006). No other factors correlated with postoperative admissions.Conclusions: Older age and history of recurrent UTIs increased patients' risks of readmission within 30 days of ureteroscopy. This finding is particularly important when hospital beds are at a premium. Older patients and patients with recurrent UTIs should be targeted for preoperative interventions to prevent readmission.
- 23 March 2025
- Published by Wiley in BJUI Compass
- Vol. 6 (3) , e70007
Open AccessRisk factors for readmission after ureteroscopy for stone disease: Modern single centre experience
Objectives: To identify factors that increase a patient's risk of readmission in the immediate postoperative period following ureteroscopy.Materials and Methods: An IRB‐approved surgical database of patients with renal and ureteral stones at a single institution was retrospectively analysed for patients who underwent ureteroscopies and had 30 days follow‐up from September 2016 to June 2019. We reviewed the most recent 600 cases (300 consecutive women and 300 consecutive men). Patient characteristics including gender, body mass index (BMI) and comorbidities (hypertension, gout, diabetes mellitus (DM), recurrent urinary tract infections (UTIs), chronic kidney disease (CKD), bowel disease), history of preoperative ED visit and surgical factors (preoperative stent, stone size) were used to conduct univariate and multivariable logistic regression analysis. Outcome measures included readmission within 30 days postoperatively. Exclusion criteria included age <18 and 0.05). Patients were more likely to have a postoperative admission if they were older (age 68 ± 15 vs 56 ± 15, p < 0.002; OR 1.06; 95% CI 1.01–1.10, p = 0.01) or had a history of recurrent UTIs (OR 7.40, 95%CI 1.78–30.67, p = 0.006). No other factors correlated with postoperative admissions.Conclusions: Older age and history of recurrent UTIs increased patients' risks of readmission within 30 days of ureteroscopy. This finding is particularly important when hospital beds are at a premium. Older patients and patients with recurrent UTIs should be targeted for preoperative interventions to prevent readmission.
- 1 January 2025
- Published by Springer Nature
- p. 109-125
Pediatric Nephrolithiasis
- 1 September 2024
- Published by SAGE Publications in Journal of Endourology
- Vol. 38 (9) , 902-907
Surgical Stone Trends from 2013 to 2021 in the US Medicare Population: Before and after the COVID-19 Pandemic
Introduction and Objective: In early 2020, as the SARS-Cov-2 (COVID-19) pandemic progressed, many institutions limited nonurgent surgical care. This coincided with a decade-long trend of increasing percutaneous nephrolithotomy (PCNL) and ureteroscopy (URS) and decreasing shock wave lithotripsy (SWL) for surgical management of urolithiasis. Herein, we evaluate temporal stone surgery rates and surgeon volumes in the Medicare population and suggest how COVID-19 contributed to them. Methods: Retrospective analysis was conducted using the “Medicare Physician & Other Practitioners” database containing data from January 2013 to December 2021. Adult patients who underwent stone surgery were included. We evaluated surgeon characteristics and changes in case volumes over time adjusted for population. Results: In 2013, urologists performed 68,910 stone surgeries: SWL 42,903 (62%); URS 25,321 (37%); PCNL 686 (1%). Over the next 8 years, there was an average annual increase in URS (+13%) and PCNL (+13%) and decrease in SWL (−2%). In 2020, there was a 14% reduction in all stone cases: SWL (−25%); URS (−6%); PCNL (−8%). By 2021, case volumes recovered to pre-2020 levels, though SWL remained low: SWL 33,974 (34%); URS 64,541 (64%); PCNL 1764 (2%). From 2013 to 2021, the number of urologists performing SWL decreased (1718 to 1361) while URS and PCNL providers doubled (1,347 to 2,914 and 28 to 76, respectively). Conclusions: From 2013 to 2021, there was an increase in URS and PCNL and a decrease in SWL in the US Medicare population. The COVID-19 pandemic was associated with a decline in stone surgeries, particularly SWL. By 2021, PCNL and URS case numbers increased significantly with a smaller increase in SWL.
- 1 September 2024
- Published by SAGE Publications in Journal of Endourology
- Vol. 38 (9) , 902-907
Surgical Stone Trends from 2013 to 2021 in the US Medicare Population: Before and after the COVID-19 Pandemic
Introduction and Objective: In early 2020, as the SARS-Cov-2 (COVID-19) pandemic progressed, many institutions limited nonurgent surgical care. This coincided with a decade-long trend of increasing percutaneous nephrolithotomy (PCNL) and ureteroscopy (URS) and decreasing shock wave lithotripsy (SWL) for surgical management of urolithiasis. Herein, we evaluate temporal stone surgery rates and surgeon volumes in the Medicare population and suggest how COVID-19 contributed to them. Methods: Retrospective analysis was conducted using the “Medicare Physician & Other Practitioners” database containing data from January 2013 to December 2021. Adult patients who underwent stone surgery were included. We evaluated surgeon characteristics and changes in case volumes over time adjusted for population. Results: In 2013, urologists performed 68,910 stone surgeries: SWL 42,903 (62%); URS 25,321 (37%); PCNL 686 (1%). Over the next 8 years, there was an average annual increase in URS (+13%) and PCNL (+13%) and decrease in SWL (−2%). In 2020, there was a 14% reduction in all stone cases: SWL (−25%); URS (−6%); PCNL (−8%). By 2021, case volumes recovered to pre-2020 levels, though SWL remained low: SWL 33,974 (34%); URS 64,541 (64%); PCNL 1764 (2%). From 2013 to 2021, the number of urologists performing SWL decreased (1718 to 1361) while URS and PCNL providers doubled (1,347 to 2,914 and 28 to 76, respectively). Conclusions: From 2013 to 2021, there was an increase in URS and PCNL and a decrease in SWL in the US Medicare population. The COVID-19 pandemic was associated with a decline in stone surgeries, particularly SWL. By 2021, PCNL and URS case numbers increased significantly with a smaller increase in SWL.
- 1 February 2024
- Published by SAGE Publications in Journal of Endourology
- Vol. 38 (2) , 205-209
Quantifying the Educational History of the Endourological Society Fellowship Programs in the United States
Introduction: We examined the history of the Endourological Society through the lens of its fellowship programs in the United States (U.S.). Methods: A review of the list of fellowship programs published annually in the Journal of Endourology from 1987 to 2015 allowed us to track the growth in fellowship programs over time. We reviewed the Endourological Society fellowship database and the websites for each of the fellowship programs for the names of graduates from each program. A survey was sent to each fellowship program director with a list of their graduates asking them to verify the names and to identify those graduates who had pursued a career in academic urology and whether they had served as fellowship program director, residency program director or department chairperson. Seventeen of the 52 U.S. program directors (33%) responded to the survey. For those programs that did not respond to the survey each graduate’s name was searched via Google, LinkedIn, and/or Doximity to determine if they had pursued a career in academic urology and served in a leadership position. Results: The number of U.S. Endourological Society fellowships has increased from 11 in 1987 to 52 in 2021. Five hundred and seventy-seven fellows have graduated from an Endourological Society Fellowship in the United States from 1987 to 2021. Two hundred and fifty fellows have pursued a career in academic urology (43.3%), 46 have served as fellowship program director (8.0%), 9 as residency program director (1.6%) and 13 have served as department chairperson (2.3%). Conclusions: The progress of the Endourological Society can be directly tied to the historical growth of its fellowship programs and the pursuit of an academic career by many of its graduates leading them to become the current and future educational leaders in the field.sup>1
- 1 February 2024
- Published by SAGE Publications in Journal of Endourology
- Vol. 38 (2) , 205-209
Quantifying the Educational History of the Endourological Society Fellowship Programs in the United States
Introduction: We examined the history of the Endourological Society through the lens of its fellowship programs in the United States (U.S.). Methods: A review of the list of fellowship programs published annually in the Journal of Endourology from 1987 to 2015 allowed us to track the growth in fellowship programs over time. We reviewed the Endourological Society fellowship database and the websites for each of the fellowship programs for the names of graduates from each program. A survey was sent to each fellowship program director with a list of their graduates asking them to verify the names and to identify those graduates who had pursued a career in academic urology and whether they had served as fellowship program director, residency program director or department chairperson. Seventeen of the 52 U.S. program directors (33%) responded to the survey. For those programs that did not respond to the survey each graduate’s name was searched via Google, LinkedIn, and/or Doximity to determine if they had pursued a career in academic urology and served in a leadership position. Results: The number of U.S. Endourological Society fellowships has increased from 11 in 1987 to 52 in 2021. Five hundred and seventy-seven fellows have graduated from an Endourological Society Fellowship in the United States from 1987 to 2021. Two hundred and fifty fellows have pursued a career in academic urology (43.3%), 46 have served as fellowship program director (8.0%), 9 as residency program director (1.6%) and 13 have served as department chairperson (2.3%). Conclusions: The progress of the Endourological Society can be directly tied to the historical growth of its fellowship programs and the pursuit of an academic career by many of its graduates leading them to become the current and future educational leaders in the field.sup>1
- 1 December 2023
- Published by SAGE Publications in Journal of Endourology
- Vol. 37 (12) , 1289-1294
The Impact of Bilateral Stone Disease on Patients' Disease Progression and Health-Related Quality of Life
Purpose Patients with recurring kidney stone events can expect significant morbidity and functional impairment. Few studies have evaluated the effect of bilateral kidney stones on disease progression and quality of life. We wanted to determine the association of bilateral stone disease on age of onset, and the impact on number of stone events and individual kidney stone disease specific Health Related Quality of Life (HRQOL) by analysing the validated and prospectively collected Wisconsin Stone Quality of Life (WISQOL) database. Material and Methods We studied 2,906 stone patients from 16 centers in North America after having completed the WISQOL questionnaire from 2014 to 2019. Kidney stone formers were assessed if kidney stones were bilateral or unilateral on imaging. Analysis with a Chi-square test compared categorical variables. Bilateral kidney stone disease and its impact on HRQOL was evaluated through a multivariable linear regression model. Results Of 2,906 kidney stone formers, 1,340 had unilateral kidney stones and 1,566 had bilateral kidney stones. We observed more frequently that patients with bilateral stones had an increased number of depression/anxiety symptoms, renal tubular acidosis, and rheumatoid arthritis (all p<0.05). Patients with bilateral stones had a younger mean (SD) age of kidney stone disease onset (37.2±15.8 vs 46.4±15.9 years of age, p<0.001). Bilateral kidney stone formers had a higher mean (SD) number of stone events (11.3±21.8) than unilateral kidney stone formers (3.0±5.1) (p<0.001). Within our multivariable analysis, we found that HRQOL was negatively affected by the presence of bilateral stones for kidney stone patients (β=-11.2 (CI:-19.5 - -3.0) points, p<0.05). Conclusion Bilateral kidney stone formers had a younger age of kidney stone disease onset and a higher number of stone events compared to unilateral kidney stone disease formers. Presence of bilateral kidney stone disease negatively impacted HRQOL.
- 1 December 2023
- Published by SAGE Publications in Journal of Endourology
- Vol. 37 (12) , 1289-1294
The Impact of Bilateral Stone Disease on Patients' Disease Progression and Health-Related Quality of Life
Purpose Patients with recurring kidney stone events can expect significant morbidity and functional impairment. Few studies have evaluated the effect of bilateral kidney stones on disease progression and quality of life. We wanted to determine the association of bilateral stone disease on age of onset, and the impact on number of stone events and individual kidney stone disease specific Health Related Quality of Life (HRQOL) by analysing the validated and prospectively collected Wisconsin Stone Quality of Life (WISQOL) database. Material and Methods We studied 2,906 stone patients from 16 centers in North America after having completed the WISQOL questionnaire from 2014 to 2019. Kidney stone formers were assessed if kidney stones were bilateral or unilateral on imaging. Analysis with a Chi-square test compared categorical variables. Bilateral kidney stone disease and its impact on HRQOL was evaluated through a multivariable linear regression model. Results Of 2,906 kidney stone formers, 1,340 had unilateral kidney stones and 1,566 had bilateral kidney stones. We observed more frequently that patients with bilateral stones had an increased number of depression/anxiety symptoms, renal tubular acidosis, and rheumatoid arthritis (all p<0.05). Patients with bilateral stones had a younger mean (SD) age of kidney stone disease onset (37.2±15.8 vs 46.4±15.9 years of age, p<0.001). Bilateral kidney stone formers had a higher mean (SD) number of stone events (11.3±21.8) than unilateral kidney stone formers (3.0±5.1) (p<0.001). Within our multivariable analysis, we found that HRQOL was negatively affected by the presence of bilateral stones for kidney stone patients (β=-11.2 (CI:-19.5 - -3.0) points, p<0.05). Conclusion Bilateral kidney stone formers had a younger age of kidney stone disease onset and a higher number of stone events compared to unilateral kidney stone disease formers. Presence of bilateral kidney stone disease negatively impacted HRQOL.
- 1 August 2023
- Published by SAGE Publications in Journal of Endourology
- Vol. 37 (8) , 948-955
Fully Automated Longitudinal Assessment of Renal Stone Burden on Serial CT Imaging Using Deep Learning
Use deep learning (DL) to automate the measurement and tracking of kidney stone burden over serial computed tomography (CT) scans. Materials and Methods This retrospective study included 259 scans from 113 symptomatic patients being treated for urolithiasis at a single medical center between 2006 and 2019. These patients underwent a standard low-dose (SLD) non-contrast CT scan followed by ultra-low dose (ULD) CT scans limited to the level of the kidneys. A DL model was used to detect, segment, and measure the volume of all stones in both initial and follow-up scans. The stone burden was characterized by the total volume of all stones in a scan (SV). The absolute and relative change of SV, (SVA and SVR, respectively) over serial scans were computed. The automated assessments were compared with manual assessments using Concordance Correlation Coefficient (CCC), and their agreement was visualized using Bland-Altman and scatter plots. Results 228/233 scans with stones were identified by the automated pipeline; per-scan sensitivity was 97.8% (95% CI: [96.0 – 99.7]). The per-scan positive predictive value was 96.6% (95% CI: [94.4 - 98.8]). The median SV, SVA and SVR were 476.5 mm3, -10 mm3 and 0.89, respectively. After removing outliers outside the 5th and 95th percentiles, the CCC measuring agreement on SV, SVA and SVR were 0.995 (0.992 – 0.996), 0.980 (0.972 – 0.986), and 0.915 (0.881 – 0.939), respectively. The mean effective dose was 4.1 mSv for the ULD compared to 13.4 mSv for the SLD (p<0.01). Conclusions The automated DL-based measurements showed good agreement with the manual assessments of the stone burden and its interval change on serial CT scans.
- 1 August 2023
- Published by SAGE Publications in Journal of Endourology
- Vol. 37 (8) , 948-955
Fully Automated Longitudinal Assessment of Renal Stone Burden on Serial CT Imaging Using Deep Learning
Use deep learning (DL) to automate the measurement and tracking of kidney stone burden over serial computed tomography (CT) scans. Materials and Methods This retrospective study included 259 scans from 113 symptomatic patients being treated for urolithiasis at a single medical center between 2006 and 2019. These patients underwent a standard low-dose (SLD) non-contrast CT scan followed by ultra-low dose (ULD) CT scans limited to the level of the kidneys. A DL model was used to detect, segment, and measure the volume of all stones in both initial and follow-up scans. The stone burden was characterized by the total volume of all stones in a scan (SV). The absolute and relative change of SV, (SVA and SVR, respectively) over serial scans were computed. The automated assessments were compared with manual assessments using Concordance Correlation Coefficient (CCC), and their agreement was visualized using Bland-Altman and scatter plots. Results 228/233 scans with stones were identified by the automated pipeline; per-scan sensitivity was 97.8% (95% CI: [96.0 – 99.7]). The per-scan positive predictive value was 96.6% (95% CI: [94.4 - 98.8]). The median SV, SVA and SVR were 476.5 mm3, -10 mm3 and 0.89, respectively. After removing outliers outside the 5th and 95th percentiles, the CCC measuring agreement on SV, SVA and SVR were 0.995 (0.992 – 0.996), 0.980 (0.972 – 0.986), and 0.915 (0.881 – 0.939), respectively. The mean effective dose was 4.1 mSv for the ULD compared to 13.4 mSv for the SLD (p<0.01). Conclusions The automated DL-based measurements showed good agreement with the manual assessments of the stone burden and its interval change on serial CT scans.
- 6 September 2022
- Published by Springer Nature
- p. 211-217
Re-Evaluating Yourself
- 6 September 2022
- Published by Springer Nature
- p. 1-7
Knowing Yourself (Edition 2)
- 1 January 2022
- Published by SAGE Publications in Journal of Endourology
- Vol. 36 (1) , 65-70
Clinical Impact of the Institution of Moses Technology on Efficiency During Retrograde Ureteroscopy for Stone Disease: Single-Center Experience
Objective: To evaluate the clinical benefits of Moses technology compared with the regular mode with the Lumenis ® Pulse™ P120H holmium laser during ureteroscopy for stone disease. Patients and Methods: An IRB-approved database of patients with urolithiasis was analyzed for ureteroscopies from January 2020 to December 2020 at an outpatient surgery center. Patients who underwent ureteroscopy with the Lumenis Pulse P120H holmium laser system with the Moses or regular mode were included. Patient characteristics and stone parameters were collected. Operative room parameters were compared, including procedural time, fragmentation/dusting time, lasing time, and total energy used. Complication rates and stone-free rates were also analyzed. Univariate analysis and multiple analysis of covariance controlling for cumulative stone size were performed. Patients with staged procedures were excluded. Results: Of 197 surgical cases, 176 met the inclusion criteria. Moses was utilized in 110 cases and regular mode in 66. There was no difference in cumulative stone size between Moses and regular modes (11.8 ± 7.9 vs 11.6 ± 9.2 mm, p = 0.901). Procedural time (43.5 ± 32.1 vs 39.8 ± 24.6 minutes, p = 0.436), fragmentation/dusting time (20.5 ± 25.3 vs 17.1 ± 16.1 minutes, p = 0.430), lasing time (7.5 ± 11.1 vs 6.7 ± 7.9 minutes, p = 0.570), and total energy used (5.1 ± 6.7 vs 3.8 ± 4.8 kJ, p = 0.093) were also similar. Complications (6.4% vs 6.1%, p = 0.936) and stone-free rates (52.3% vs 65.3%, p = 0.143) did not differ. Conclusion: At our institution, Moses technology did not significantly change the procedural time, fragmentation/dusting time, lasing time, or total energy used. Moreover, there were no differences in complications or stone-free rates. There may be technical benefits to the Moses technology not captured in this analysis.
- 1 January 2022
- Published by SAGE Publications in Journal of Endourology
- Vol. 36 (1) , 65-70
Clinical Impact of the Institution of Moses Technology on Efficiency During Retrograde Ureteroscopy for Stone Disease: Single-Center Experience
Objective: To evaluate the clinical benefits of Moses technology compared with the regular mode with the Lumenis ® Pulse™ P120H holmium laser during ureteroscopy for stone disease. Patients and Methods: An IRB-approved database of patients with urolithiasis was analyzed for ureteroscopies from January 2020 to December 2020 at an outpatient surgery center. Patients who underwent ureteroscopy with the Lumenis Pulse P120H holmium laser system with the Moses or regular mode were included. Patient characteristics and stone parameters were collected. Operative room parameters were compared, including procedural time, fragmentation/dusting time, lasing time, and total energy used. Complication rates and stone-free rates were also analyzed. Univariate analysis and multiple analysis of covariance controlling for cumulative stone size were performed. Patients with staged procedures were excluded. Results: Of 197 surgical cases, 176 met the inclusion criteria. Moses was utilized in 110 cases and regular mode in 66. There was no difference in cumulative stone size between Moses and regular modes (11.8 ± 7.9 vs 11.6 ± 9.2 mm, p = 0.901). Procedural time (43.5 ± 32.1 vs 39.8 ± 24.6 minutes, p = 0.436), fragmentation/dusting time (20.5 ± 25.3 vs 17.1 ± 16.1 minutes, p = 0.430), lasing time (7.5 ± 11.1 vs 6.7 ± 7.9 minutes, p = 0.570), and total energy used (5.1 ± 6.7 vs 3.8 ± 4.8 kJ, p = 0.093) were also similar. Complications (6.4% vs 6.1%, p = 0.936) and stone-free rates (52.3% vs 65.3%, p = 0.143) did not differ. Conclusion: At our institution, Moses technology did not significantly change the procedural time, fragmentation/dusting time, lasing time, or total energy used. Moreover, there were no differences in complications or stone-free rates. There may be technical benefits to the Moses technology not captured in this analysis.
- 1 October 2021
- Published by SAGE Publications in Journal of Endourology
- Vol. 35 (10) , 1443-1447
Flexible Ureteroscopy as the New Standard for the Management of Renal Transplant Urolithiasis <15 mm: A Single-Center Experience
Objectives: To determine the safety and efficacy of flexible ureteroscopy in the treatment of transplant urolithiasis. Material & Methods: We reviewed a single center series of 2,652 patients who underwent surgical treatment for nephrolithiasis at our institution from 2009 to the present day to identify all patients undergoing ureteroscopy for treatment of transplant lithiasis. Results: We identified 18 patients who underwent ureteroscopy for treatment of urolithiasis within the transplanted kidney or ureter. The majority of the procedures were performed using a retrograde approach with flexible ureteroscopy, with one patient undergoing antegrade ureteroscopy and two patients requiring semi-rigid ureteroscopy. Holmium:yttrium-aluminum-garnet laser lithotripsy was utilized in all but one case, which was performed using basket extraction. There were no intraoperative complications reported. Four patients had small stone fragments on postoperative imaging, three of which were observed. One patient required repeat ureteroscopy for persistent distal ureteral stone. Conclusion: Retrograde ureteroscopy is a feasible, safe and effective intervention for the treatment of transplant lithiasis. Minimal intraoperative or postoperative complications were reported and only one patient required additional intervention for residual stone burden.
- 1 October 2021
- Published by SAGE Publications in Journal of Endourology
- Vol. 35 (10) , 1443-1447
Flexible Ureteroscopy as the New Standard for the Management of Renal Transplant Urolithiasis <15 mm: A Single-Center Experience
Objectives: To determine the safety and efficacy of flexible ureteroscopy in the treatment of transplant urolithiasis. Material & Methods: We reviewed a single center series of 2,652 patients who underwent surgical treatment for nephrolithiasis at our institution from 2009 to the present day to identify all patients undergoing ureteroscopy for treatment of transplant lithiasis. Results: We identified 18 patients who underwent ureteroscopy for treatment of urolithiasis within the transplanted kidney or ureter. The majority of the procedures were performed using a retrograde approach with flexible ureteroscopy, with one patient undergoing antegrade ureteroscopy and two patients requiring semi-rigid ureteroscopy. Holmium:yttrium-aluminum-garnet laser lithotripsy was utilized in all but one case, which was performed using basket extraction. There were no intraoperative complications reported. Four patients had small stone fragments on postoperative imaging, three of which were observed. One patient required repeat ureteroscopy for persistent distal ureteral stone. Conclusion: Retrograde ureteroscopy is a feasible, safe and effective intervention for the treatment of transplant lithiasis. Minimal intraoperative or postoperative complications were reported and only one patient required additional intervention for residual stone burden.